Williams & Novak’s PIMCO RAFI Dynamic Multi-Factor Emerging Markets Equity ETF MFEM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$5.91M Buy
206,843
+28,387
+16% +$795K 3.5% 6
2026
Q2
$5.04M Buy
178,456
+9,399
+6% +$263K 3.33% 6
2026
Q1
$4.23M Buy
169,057
+24,877
+17% +$634K 3.17% 6
2025
Q4
$3.33M Buy
144,180
+5,264
+4% +$120K 2.51% 8
2025
Q3
$3.13M Buy
138,916
+530
+0.4% +$11.5K 2.41% 8
2025
Q2
$2.93M Buy
138,386
+11,654
+9% +$228K 2.49% 5
2025
Q1
$2.41M Buy
126,732
+25,650
+25% +$490K 2.36% 6
2024
Q4
$1.92M Buy
101,082
+44,581
+79% +$892K 1.85% 10
2024
Q3
$1.2M Buy
56,501
+44,889
+387% +$906K 1.12% 27
2024
Q2
$238K Buy
11,612
+1,130
+11% +$22.6K 0.22% 94
2024
Q1
$201K Hold
10,482
– – 0.23% 80
2023
Q4
$201K Buy
+10,482
New +$189K 0.23% 80

Other funds holding MFEM

Williams & Novak's MFEM Position: Q3 2026 in Review

Williams & Novak increased its PIMCO RAFI Dynamic Multi-Factor Emerging Markets Equity ETF (MFEM) stake by 16% in Q3 2026, buying an estimated $795K and bringing the position to 206,843 shares worth $5.91M. The position accounts for 3.5% of the portfolio, ranked #6.

Williams & Novak first reported a position in MFEM in Q4 2023 and has held it in 12 quarters since. 7 funds tracked by Wall St. Rank hold MFEM as of Q3 2026.

  • Williams & Novak held 206,843 shares of PIMCO RAFI Dynamic Multi-Factor Emerging Markets Equity ETF worth $5.91M as of Q3 2026.
  • Williams & Novak bought 28,387 PIMCO RAFI Dynamic Multi-Factor Emerging Markets Equity ETF shares in Q3 2026, an estimated $795K.
  • PIMCO RAFI Dynamic Multi-Factor Emerging Markets Equity ETF made up 3.5% of Williams & Novak's portfolio in Q3 2026, its #6 holding.
  • Williams & Novak first reported a position in PIMCO RAFI Dynamic Multi-Factor Emerging Markets Equity ETF in Q4 2023 and has held it in 12 quarters since.
  • 7 funds tracked by Wall St. Rank held PIMCO RAFI Dynamic Multi-Factor Emerging Markets Equity ETF as of Q3 2026.

Based on Williams & Novak's 13F filing for Q3 2026, filed 9 Oct 2026.